CPIX stock forecast
Our latest prediction for Cumberland Pharmaceuticals, Inc.'s stock price was made on the Sept. 19, 2019 when the stock price was at 5.29$.
In the short term (2weeks), CPIX's stock price should outperform the market by 1.78%. During that period the price should oscillate between -6.27% and +10.11%.
In the medium term (3months), CPIX's stock price should outperform the market by 3.83%. During that period the price should oscillate between -13.14% and +24.52%.Get email alerts
About Cumberland Pharmaceuticals, Inc.
Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Hepatoren, Vaprisol, Boxaban, Vasculan, Ethyol, Portaban, and Totect. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.
At the moment the company generates 45M USD in revenues.
On its last earning announcement, the company reported a loss of -0.28$ per share.
The book value per share is 3.84$
Three months stock forecastSept. 19, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|